Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 267

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Copeptin: A novel, independent prognostic marker in patients with ischemic stroke

Katan, Mira, Fluri, Felix, Morgenthaler, Nils G., Schuetz, Philipp, Zweifel, Christian, Bingisser, Roland, Müller, Klaus, Meckel, Stephan, Gass, Achim, Kappos, Ludwig, Steck, Andreas J., Engelter, Stefan T., Müller, Beat, Christ‐Crain, Mirjam·2009·Annals of Neurology

Abstract

Objective: Early prediction of outcome in patients with ischemic stroke is important. Vasopressin is a stress hormone. Its production rate is mirrored in circulating levels of copeptin, a fragment of provasopressin. We evaluated the prognostic value of copeptin in acute stroke patients. Methods: In a prospective observational study, copeptin was measured using a new sandwich immunoassay on admission in plasma of 362 consecutive patients with an acute ischemic stroke. The prognostic value of copeptin to predict the functional outcome (defined as a modified Rankin Scale score of ≤2 or ≥3), mortality within 90 days, was compared with the National Institutes of Health Stroke Scale score and with other known outcome predictors. Results: Patients with an unfavorable outcomes and nonsurvivors had significantly increased copeptin levels on admission (p <0.0001 and p <0.0001). Receiver operating characteristics to predict functional outcome and mortality demonstrated areas under the curve of copeptin of 0.73 (95% confidence interval [CI], 0.67–0.78) and 0.82 (95% CI, 0.76–0.89), which was comparable with the National Institutes of Health Stroke Scale score but superior to C‐reactive protein and glucose (p <0.01). In multivariate logistic regression analysis, copeptin was an independent predictor of functional outcome and mortality, and improved the prognostic accuracy of the National Institutes of Health Stroke Scale to predict functional outcome (combined areas under the curve, 0.79; 95% CI, 0.74–0.84; p <0.01) and mortality (combined areas under the curve, 0.89; 95% CI, 0.84–0.94; p <0.01). Interpretation: Copeptin is a novel, independent prognostic marker improving currently used risk stratification of stroke patients. Ann Neurol 2009;66:799–808

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.21783

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 51 references

Cited by

See all 267

Metadata

Authors
Katan, M., Fluri, F., Morgenthaler, N. G., Schuetz, P., Zweifel, C., Bingisser, R., Müller, K., Meckel, S., Gass, A., Kappos, L., Steck, A. J., Engelter, S. T., Müller, B., & Christ‐Crain, M.
Venue
Annals of Neurology
Publisher
Wiley
Published
2009-12
Volume
66
Issue
6
Pages
799-808
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W2088794031
Cited by
267
References
51
FWCI
11.72
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Copeptin: A novel, independent prognostic marker in patients with ischemic stroke. https://app.cochat.ai/papers/10.1002/ana.21783
The paper
Katan, M., Fluri, F., Morgenthaler, N. G., Schuetz, P., Zweifel, C., Bingisser, R., Müller, K., Meckel, S., Gass, A., Kappos, L., Steck, A. J., Engelter, S. T., Müller, B., & Christ‐Crain, M. (2009). Copeptin: A novel, independent prognostic marker in patients with ischemic stroke. Annals of Neurology. https://doi.org/10.1002/ana.21783

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.